We are a specialty pharmaceutical company focused on developing and commercializing injectable products,
primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway. Our goal is to enter the market before any generics with enhanced versions of existing injectable drugs.
Speciality pharmaceutical company focused on developing and commercializing products for hospital and outpatient infusion clinics.
Formulation technology and know-how, patent strategy, and market understanding drive product development and Eagle's ability to create value.